Thioacetazone

Thioacetazone

Structural formula of thioacetazone
Space-filling model of thioacetazone
Systematic (IUPAC) name
N-{4-[(ethanethioamidoimino)methyl]phenyl}acetamide
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
Identifiers
CAS Number	104-06-3
ATC code	J04AM04 (WHO)
PubChem	CID: 9568512
ChemSpider	7843221 Y
UNII	MMG78X7SSR Y
KEGG	D08584 Y
ChEMBL	CHEMBL375492
Synonyms	N-[4-[(carbamothioylhydrazinylidene) methyl]phenyl]acetamide
Chemical data
Formula	C10H12N4OS
Molecular mass	236.3
SMILES O=C(Nc1ccc(cc1)\C=N\NC(=S)N)C
InChI InChI=1S/C10H12N4OS/c1-7(15)13-9-4-2-8(3-5-9)6-12-14-10(11)16/h2-6H,1H3,(H,13,15)(H3,11,14,16)/b12-6+ Y Key:SRVJKTDHMYAMHA-WUXMJOGZSA-N Y
(verify)

Thioacetazone (INN and BAN) is also called thiocetazone, thiacetazone, thiosemicarbazone, benzothiozane or amithiozone (USAN); abbreviated T.

Thioacetazone is used in the treatment of tuberculosis; it has only weak activity against Mycobacterium tuberculosis and is only useful in preventing resistance to more powerful drugs like isoniazid and rifampicin. It is never used on its own to treat tuberculosis; it is used in a similar way to ethambutol. Thioacetazone is the only anti-TB drug that is ineffective when given intermittently.

There is no advantage to using thioacetazone if the regimen used already contains ethambutol, but many countries in sub-Saharan Africa still use thioacetazone because it is extremely cheap. Use of thioacetazone is declining because it can cause severe (sometimes fatal) skin reactions in HIV positive patients.